Author

Mario Martínez‐Mingo

IMDEA NanoscienceORCID 0000-0002-2963-5769Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Adriana de Bonis· 1 shared Almudena R. RamiroiD· 1 shared Álvaro SomozaiD· 1 shared Belén S. EstradaiD· 1 shared Carmen Gómez‐EscolariD· 1 shared Emigdio Álvarez-CorralesiD· 1 shared Magdalena LeivaiD· 1 shared María Laguna-Herrero· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adriana de Bonis

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting of ibrutinib resistance driving pathways by miR-28 in ABC-DLBCL

Emigdio Álvarez-Corrales, Rocío Moreno-Palomares, Carmen Gómez‐Escolar, Mario Martínez‐Mingo, Udane Moral-Pérez, María Laguna-Herrero, Teresa Fuertes, Belén S. Estrada, Sonia M. Mur, Adriana de Bonis, Magdalena Leiva, Núria Martínez, Álvaro Somoza, Almudena R. Ramiro, Virginia G. de Yébenes

This study shows miR-28 inhibits ibrutinib resistance in ABC-DLBCL by targeting mitochondrial and mTOR pathways and improves survival in treated patients.

Leukemia · Apr 8, 2026Peer-reviewedCancer Biology